focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.825
Bid: 1.80
Ask: 1.85
Change: -0.173 (-8.66%)
Spread: 0.05 (2.778%)
Open: 1.825
High: 1.85
Low: 1.825
Prev. Close: 1.998
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

5 Dec 2022 07:00

RNS Number : 4815I
Genedrive PLC
05 December 2022
 

 

 

genedrive plc

("genedrive" or the "Company")

 

Annual Report and Accounts and date of AGM

 

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that its 2022 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.php The Notice of the 2022 Annual General Meeting ("AGM") and hard copies of the 2022 Annual Report and Accounts will be posted to shareholders on or around 5 December 2022.

 

The Company's AGM will be held at 11am on 29 December 2022 at 46 Grafton Street, Manchester M13 9XX.

 

 

For further details please contact:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOABXBDDCDGDGDD
Date   Source Headline
28th May 20214:35 pmRNSPrice Monitoring Extension
6th May 20212:05 pmRNSSecond Price Monitoring Extn
6th May 20212:00 pmRNSPrice Monitoring Extension
30th Apr 20217:00 amRNSCOVID-19 PCR test approved by Indian regulator
23rd Apr 20217:00 amRNSExcellent performance data for Genedrive® HCV test
19th Apr 20217:00 amRNSPHE National Framework Agreement
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 202111:05 amRNSSecond Price Monitoring Extn
31st Mar 202111:00 amRNSPrice Monitoring Extension
25th Mar 20217:00 amRNSHalf-year Report
9th Mar 20217:00 amRNSDistribution agreement
3rd Mar 20217:00 amRNSAntibiotic Induced Hearing Loss update
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSInvestor Presentation
1st Mar 20217:00 amRNSTotal Voting Rights
17th Feb 20217:00 amRNSFirst US shipments of Genedrive® 96 SARS-CoV-2 Kit
12th Feb 20212:10 pmRNSHolding(s) in Company
10th Feb 20219:05 amRNSSecond Price Monitoring Extn
10th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20212:28 pmRNSHolding(s) in Company
8th Feb 20213:30 pmRNSHolding(s) in Company
8th Feb 202112:51 pmRNSHolding(s) in Company
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20212:05 pmRNSHolding(s) in Company
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20211:22 pmRNSHolding(s) in Company
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTotal Voting Rights
29th Jan 20219:05 amRNSSecond Price Monitoring Extn
29th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20219:05 amRNSSecond Price Monitoring Extn
28th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSDistribution agreement with Beckman Coulter
25th Jan 202111:35 amRNSHolding(s) in Company
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
18th Jan 202112:29 pmRNSHolding(s) in Company
18th Jan 20217:00 amRNSNotice of Results
30th Dec 202012:50 pmRNSResult of AGM
23rd Dec 202011:39 amRNSHolding(s) in Company
21st Dec 20202:48 pmRNSResponse to new COVID strain
17th Dec 20209:12 amRNSHolding(s) in Company
16th Dec 20209:05 amRNSSecond Price Monitoring Extn
16th Dec 20209:00 amRNSPrice Monitoring Extension
16th Dec 20207:00 amRNSNotification of intent to distribute in the USA
11th Dec 20207:00 amRNSConversion of Remaining Loan Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.